Efficacy and Safety of Doravirine in the Rapid Initiation
NCT07357584
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
HIV-1-infection
Interventions
DRUG:
Doravirine / lamivudine/ Tenofovir Disoproxil Oral Tablet
Sponsor
Fundación Huésped
Collaborators
[object Object]
[object Object]